Lph Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.50 Cr
as on 16-11-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.10 Cr
as on 16-11-2024
- Revenue 40.65%
(FY 2023)
- Profit 123.89%
(FY 2023)
- Ebitda 36.88%
(FY 2023)
- Net Worth 948.77%
(FY 2023)
- Total Assets 37.25%
(FY 2023)
About Lph Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹9.00 Cr. The company has closed loans amounting to ₹1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Palepu Gopal and Palepu Prasad serve as directors at the Company.
- CIN/LLPIN
U24231TN1995PTC033975
- Company No.
033975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lph Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palepu Gopal  | Director | 23-Jan-2017 | Current |
| Palepu Prasad | Director | 22-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Lph Pharma.
Lph Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.65% increase. The company also saw a substantial improvement in profitability, with a 123.89% increase in profit. The company's net worth Soared by an impressive increase of 948.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lph Pharma?
In 2023, Lph Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pleasant Foods Private LimitedActive 35 years 8 months
Palepu Gopal and Palepu Prasad are mutual person
- Shanbalaji Pharma Distributors Private LimitedActive 2 years 7 months
Palepu Gopal is a mutual person
- Palepu Pharma Distributors Private LimitedActive 2 years 8 months
Palepu Gopal and Palepu Prasad are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Jun 2017 | ₹9.00 Cr | Open |
Punjab National Bank Creation Date: 02 Dec 1996 | ₹1.10 Cr | Satisfied |
How Many Employees Work at Lph Pharma?
Lph Pharma has a workforce of 48 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lph Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lph Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
